JPH11158077A - Composition having alleviating effect on stress - Google Patents

Composition having alleviating effect on stress

Info

Publication number
JPH11158077A
JPH11158077A JP9347191A JP34719197A JPH11158077A JP H11158077 A JPH11158077 A JP H11158077A JP 9347191 A JP9347191 A JP 9347191A JP 34719197 A JP34719197 A JP 34719197A JP H11158077 A JPH11158077 A JP H11158077A
Authority
JP
Japan
Prior art keywords
composition
stress
hemerocallis
fructus
var
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9347191A
Other languages
Japanese (ja)
Inventor
Tetsuo Ikegawa
川 哲 郎 池
Osamu Nakajima
島 修 中
Suehito Yamagami
上 末 人 山
Seika En
世 華 袁
Yoshiaki Ishihama
濱 義 明 石
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NISSEI MARINE KOGYO KK
Original Assignee
NISSEI MARINE KOGYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NISSEI MARINE KOGYO KK filed Critical NISSEI MARINE KOGYO KK
Priority to JP9347191A priority Critical patent/JPH11158077A/en
Publication of JPH11158077A publication Critical patent/JPH11158077A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a composition consisting essentially of Hemerocallis disticha Donn var. kwanso Nakai, usable as medicines and healthy foods and useful for effects on an improvement of diseases in neural functions, sleep symptoms, etc., and alleviating effects on stress. SOLUTION: This composition is obtained by using Hemerocallis disticha Donn var. kwanso Nakai, preferably a flower bud of Hemerocallis fulva L., Zizyphi Spinosi Semen, Lilii Bulbus, Albizziae Flos and Nelumbinis Fructus as principal ingredients and further including one or more of Concha Margaritifera Usta, Zizyphi Inermi Fructus, Glycyrrhizae Radix, Acanthopanax Cortex, etc., a dried leaf of Eucommia ulmoides Oliver, Rhemanniae Rhizoma, Chrysanthemi Flos, Coicis Semen, a leaf of Ginkgo biloba L., Aurantii Nobilia Pericarpium, Ganoderma lucidum Karst. and Hordeum vulgare L. The composition preferably contains <=30% of the Hemerocallis disticha Donn var. kwanso Nakai, the flower bud of the Hemerocallis fulva L., Zizyphi Spinosi Semen and Nelumbinis Fructus, <=20% of the Lilii Bulbus, Albizziae Flos, Acanthopanax Cortex, etc., and Concha Margaritifera Usta and <=10% of the Hordeum vulgare L, Zizyphi Inermi Fructus and Glycyrrhizae Radix in the ingredients. Furthermore, 15±5% of the Hemerocallis disticha Donn var. kwanso Nakai, 10±5% of the flower bud of the Hemerocallis fulva L., Albizziae Flos, Concha Margaritifera Usta and Acanthopanax Cortex, etc., 18±5% of the Zizyphi Spinosi Semen, 7±5% of the Hordeum vulgare L., ZZizyphi Inermi Fructus and Glycyrrhizae Radix and 3±3% of the Lilii Bulbus and Nelumbinis Fructus are preferably contained. Furthermor, <=5±3% of melatonin is preerably added thereto.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】この発明は薬用あるいは健康
食品として用いることが可能なストレスを軽減する効果
を有する組成物であり、時に健全な睡眠をもたらす効果
を有する組成物に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition which can be used as a medicinal or health food and has an effect of reducing stress, and more particularly to a composition which has an effect of bringing healthy sleep.

【0002】[0002]

【発明が解決しようとする課題】我が国をはじめ欧米先
進国では、種々の面で高度な競争が繰り広げられてお
り、それを支える勤労者にはストレスが否応無く蓄積す
る。しかし、現代医学はストレスに対する効果的な対応
ができず、それがまたいろいろな慢性病を生むような状
況である。例えば、睡眠剤を取ってみても、ただ睡眠中
枢を刺激することに主眼がおかれ、身体全体が考慮され
てこなかったと言える。このようなストレスに対する漢
方医学の対応は古書物にも見られ、身体全体の改善を促
す漢方生薬が用いられていた。本発明は、ストレス軽減
効果を有する組成物を提供することを目的とする。
In Japan, the United States and other advanced nations, there is a high level of competition in various fields, and stress is accumulated in the workers who support it. However, modern medicine is unable to respond effectively to stress, which is another situation that causes various chronic diseases. For example, even when taking sleeping pills, it can be said that the main focus was merely on stimulating the sleep center and the whole body was not considered. The response of Kampo medicine to such stress has been seen in old books, and Chinese herbal medicines that promote the improvement of the whole body have been used. An object of the present invention is to provide a composition having a stress reducing effect.

【0003】[0003]

【課題を解決するための手段】上記目的を達成するため
に、本発明は忘憂草又はこれに加えて萱草花を主成分と
することを特徴とする。本発明者らは、前述したように
社会の要請に応ずるために研究を重ね、漢方医学あるい
は中国伝統医学で西洋医学を補うような漢方処方を考案
し研究を行った。その結果、本発明による組成物がスト
レス軽減に役立ち、また健全な睡眠をもたらす結果を有
すことを見いだした。一般に医学的にストレスによって
起こると考えられる神経症、神経衰弱、更年期障害、老
年性欝病、そのほか疲労症候群について臨床研究が行わ
れ、上記組成物がこれらのストレス性の疾患に対して効
果があることが確認された。上記成分に加えて、更に酸
棗仁、百合、合歓花及び蓮心を加えることにより効果が
向上する。また更に真珠母、大棗、甘草、五加参、杜仲
葉、地黄茎、菊花、苡米、銀杏葉、陳皮、霊芝、大麦の
中の1以上を添加することができる。また上記成分は忘
憂草と萱草花と酸棗仁と蓮心とを30%以下、百合と合
歓花と五加参と真珠母とを夫々20%以下、大麦と大棗
と甘草とを夫々10%以下の配合比にするのが望まし
く、更に、忘憂草を15±5%、萱草花と合歓花と真珠
母と五加参とを夫々10±5%、酸棗仁を18±5%、
大麦と大棗と甘草とを夫々7±5%、百合と蓮心とを夫
々3±3%の配合比とするのが望ましい。また、上記成
分にメラトニン5%以下を添加することも可能である。
なお、上記成分比は真珠母とメラトニンを除いて、各薬
草を刻み、エキスを抽出した後乾燥末としたものの重量
比である。真珠母については直接くだいて末としたもの
を用いている
In order to achieve the above-mentioned object, the present invention is characterized in that the main ingredient is forget-me-not or herb. As described above, the present inventors have repeatedly conducted research to meet the needs of society, devised and conducted research on Kampo medicines that supplement Western medicine with Chinese medicine or Chinese traditional medicine. As a result, it has been found that the composition according to the invention helps to reduce stress and has the consequence of providing a healthy sleep. Clinical studies have been conducted on neurosis, nervous breakdown, menopause, senile depression, and other fatigue syndromes that are generally considered to be caused by medical stress, and the above composition is effective for these stress-related diseases. It was confirmed that. In addition to the above components, the effect is improved by further adding acid jujube, lily, lily flower and lotus heart. Further, one or more of mother of pearl, large jujube, licorice, five ginseng, eucalypt, ground yellow stalk, chrysanthemum, ox rice, ginkgo biloba, cinnamon, reishi, and barley can be added. In addition, the above ingredients are 30% or less of forgetfulness, kaya grass flower, acid jujube and lotus root, 20% or less of lily, happiflower, gokasan and pearl mother, respectively, and 10% of barley, large jujube and licorice each. It is desirable to make the following composition ratios, and furthermore, 15 ± 5% for forgetfulness, 10 ± 5% for each of Kaya flower, Ganhua flower, mother of pearl and Gokasan, 18 ± 5% for acid jujube,
It is preferable that the barley, the jujube, and the licorice have a mixing ratio of 7 ± 5%, respectively, and the lily and the lotus root have a mixing ratio of 3 ± 3%, respectively. It is also possible to add 5% or less of melatonin to the above components.
The above-mentioned component ratio is the weight ratio of each herb, excluding the mother of pearl and melatonin, and after extracting the extract to dry powder. The mother-of-pearl is directly obtained from the mother

【0004】[0004]

【発明の実施の形態】以下本発明の実施の形態を説明す
る。本発明の組成物に用いる、各成分を説明する。本発
明の組成物は忘憂草又はこれに加えて萱草花を必須とす
る。 <忘憂草>忘憂草はユリ科植物の萱草(かんぞう)のこ
とであり、これの葉と茎のエキスを抽出、乾燥して粉末
として用いる。この忘憂草は鎮静効果があり、不眠解消
及び眼精疲労の解消などの効果がある。 <萱草花>忘憂草の花の蕾であり、金針菜或いは黄花菜
として知られ、料理に用いられている。これも同様にエ
キスを抽出し、乾燥させて粉末として用いる。上記に更
に、酸棗仁、百合、合歓花、蓮心を加えると効果が高
い。 <酸棗仁>酸棗仁はクロウメモドキ科(Rhamnaceae)の
サネブトナツメ Zizyphus jujubaMILL. var. spinosa H
U(=Z. vulgaris LAMARK. var. supinosus BUNGE, Z. su
pinosus HU)の種子を乾燥したものであり、鎮静作用が
ある。 <百合>ユリ科(Liliaceae)のLilium brownii F. E.
BROWN var. colchesteri WILS., ハカタユリL. browni
i F. E. BR., イトハユリL. tenuifolium FISCH., オ
ニユリL. lancifolium THUNB., ヒメユリL. concolor
SALISB.などLilium spp.の鱗茎の鱗片を乾燥したもの。
まれにヤマユリL. auratum LINDL., ササユリL.japoni
cum THUNB., オニユリL. lancifolium THUNB. などの鱗
茎を用いる。 〔産地〕中国 〔成分〕多量の澱粉を含み、そのほか脂肪、蛋白質など
を含有する。その他未詳。 〔薬理作用〕未詳。 〔薬味、薬性〕甘。平。 〔薬能〕百合は、心、肺、脾の三経に入り、清肺、養脾
の効があり、また鎮咳、止渇の作用がある。隠虚証の発
熱、咳嗽、吐血の症に用いて効果がある。 <合歓花>合歓花はマメ科(Leguminosae)のネムノキ
Albizzia julibrissinDURAZZ. の花蕾であり、鎮静、
健胃効果がある。 <蓮心>蓮心は、スイレン科(Nymphaeaceae)のハス N
elumbo nucifera GAERTNERの成熟果実を乾燥したものを
「石蓮子」又は「蓮実」と称し、穀をはぎとった種子を
「蓮肉」と称する。中国(湖南、湖北、福建、台湾、江
蘇、浙江、江西省など)に主産する。果皮の成分は未
詳。種子の組成は蛋白質16.6%、脂肪2.0%、炭
水化物62.0%、Ca0.089%、P0.285
%、Fe0.0064%である。多量の澱粉のほか raf
finose を含む。また各種のアルカロイドを含む。すな
わち蓮子芯(芽 NELUMBINIS EMBRYO) にmethylcorypal
ine(I)、lotusine chloride(II)、demethylcocl
aurine(III)、isoliensinine(IV)、liensinin
e(V)、neferine(VI)、N-nornuciferine、O-norn
uciferine(VII)、(+)-pronuciferine(VII
I)などが見いだされている。また蓮房にもd-(−)-N
-norarmepavine(IX)、liriodenine(X)、N-norn
uciferine、nuciferineなどが含まれている。 〔薬理作用〕methylcorypalline には冠状血管拡張作用
があり、demethylcoclaurine には子宮平滑筋弛緩作用
があることが報告されている。 〔薬能〕蓮肉は生では胃を養い、心を清め、熱すれば腸
を厚くし、腎を固める。一般に益脾、養心、止泄、固精
の効があり、脾虚により久瀉、夢精、失眠、崩漏帯下、
久痢下血を治す。石蓮子は清心、除煩の効があり、噤口
痢に専用する。蓮子芯は清心、解熱の効があり、また安
神、止渇の作用があり、心煩、口渇、吐血、遺精などを
治す。
Embodiments of the present invention will be described below. Each component used in the composition of the present invention will be described. The compositions of the present invention require a forget-me-not or herb flower. <Melancholy> The melancholy is a lily plant, kanzo, whose leaves and stem extracts are extracted, dried and used as a powder. This melancholy has a sedative effect, and has effects such as relieving insomnia and asthenopia. <Kayasohana> A bud of a forget-me-not flower, also known as golden needle vegetables or yellow flower vegetables, and is used in cooking. Similarly, the extract is extracted, dried and used as a powder. In addition to the above, it is effective to add acid jujube, lily, bonsai and lotus. <Satsuma Jin> Satsuma Jin is a juvenile juvenile of the buckthorn family (Rhamnaceae) Zizyphus jujubaMILL. Var. Spinosa H
U (= Z.vulgaris LAMARK.var.supinosus BUNGE, Z. su
pinosus HU) is a dried seed that has a sedative effect. <Yuri> Lilium brownii FE of the lily family (Liliaceae)
BROWN var. Colchesteri WILS., Hakata lily L. browni
i FE BR., Itoha lily L. tenuifolium FISCH., Oni lily L. lancifolium THUNB., Hime lily L. concolor
Dried scales of Lilium spp. Bulbs such as SALISB.
Rarely Yamayuri L. auratum LINDL., Sasa lily L. japoni
Use bulbs such as cum THUNB., L. lancifolium THUNB. [Origin] China [Ingredients] Contains a large amount of starch, and also contains fat, protein, etc. Other unknown. [Pharmacological action] Unknown. [Spicy, medicinal] Sweet. flat. [Medicinal properties] Yuri enters the heart, lungs and spleen, and has the effect of lung cleansing and spleen feeding, as well as antitussive and depleting effects. It is effective for fever, cough, and vomiting. <Happiness flower> Happiness flower is leguminosae (Leguminosae)
The flower bud of Albizzia julibrissinDURAZZ.
Has a stomach effect. <Renshin> Lotus is a lotus N of Nymphaeaceae
The dried mature fruit of elumbo nucifera GAERTNER is referred to as "stone lotus" or "lotus fruit", and the seeds obtained by removing the grain are referred to as "lotus meat". It is mainly produced in China (Hunan, Hubei, Fujian, Taiwan, Jiangsu, Zhejiang, Jiangxi, etc.). The components of the skin are unknown. The composition of the seed is 16.6% protein, 2.0% fat, 62.0% carbohydrate, 0.089% Ca, 0.285 P
% And 0.0064% of Fe. In addition to large amounts of starch raf
Including finose. Also includes various alkaloids. In other words, methylcorypal is added to the lotus root (bud NELUMBINIS EMBRYO)
ine (I), lotusine chloride (II), demethylcocl
aurine (III), isoliensinine (IV), liensinin
e (V), neferine (VI), N-nornuciferine, O-norn
uciferine (VII), (+)-pronuciferine (VII
I) has been found. D-(-)-N
-norarmepavine (IX), liriodenine (X), N-norn
It contains uciferine, nuciferine, etc. [Pharmacological action] It has been reported that methylcorypalline has a coronary vasodilatory action and demethylcoclaurine has a uterine smooth muscle relaxing action. [Medicinal properties] Lotus meat feeds the stomach and cleanses the heart when raw, and when heated, thickens the intestines and solidifies the kidneys. In general, it has the effects of spleen, nourishing, excretion, and solidity.
Cures diarrhea and blood. Shirenko is pure and depressing, and is used exclusively for dysentery. Renko wick has the effect of clarifying and relieving fever, and has the effect of Anjin and thirst, and cures anxiety, thirst, bloody bleeding, and sperm.

【0005】以上のものに更に次の成分の1又は1以上
を加えることが望ましい。各成分の内容を示す。 <真珠母>真珠母は、真珠カルシウム(ベータカルク)
である。カルシウムは骨格及び歯牙の主成分として極め
て重要であるばかりでなく、血中のカルシウム濃度が低
下すると、神経の興奮性が以上に高まることがあきらか
にされている。不眠にカルシウムの摂取は欠かせない。
カルシウムとしては、真珠カルシウム、卵殻カルシウ
ム、カキ殻カルシウム、マローカルシウム、乳清カルシ
ウム等があるが、カルシウムはとかく吸収に問題がある
といわれているが、真珠母は吸収効率が高いという特徴
を有する。 <大棗>大棗は、クロウメモドキ科(Rhamnaceae)のナ
ツメ Ziyphus jujuba MILL. var. inermis (BUNGE) REH
D.(=Z. vulgaris LAMARK var. inermis BUNGE) または
その品種の果実を乾燥したものであり、強壮作用があ
る。 <甘草>甘草は、マメ科(Leguminosae)のナンキンカ
ンゾウ(西北甘草)Glycyrrhiza glabra L. var. gland
uligera REG. et HERD.(=G. glanduliferaWALDSTEIN et
KITAIBEL) およびウラルカンゾウ(東北甘草) Glycyr
rhizauralensis FISH. ex DC. の根およびストロンを乾
燥したものであり、強壮効果がある。 <五加参>五加参は、ウコギ科(Araliaceae)のウコギ
Acanthopanax 属植物の根皮及び幹皮である。現在中国
市場には、北五加皮(香五加皮、杠柳皮)、南五加皮、
紅毛五加皮の3種が主であり、そのうち北五加皮が最も
多く用いられている。その他地方によって更に多くの種
類がある。五加皮は風を除き、筋を強める薬であり、且
つ鎮痛作用がある。通利の薬物を配合して除風、除湿に
用い、また強壮剤と配合して、堅骨、強筋に用いる。そ
れゆえ、リウマチのような風湿痺痛、足膝痿痛に用い、
また水腫などの諸症にも応用する。 <杜仲葉>杜仲葉は、トチュウ科(Eucommiaceae)のト
チュウ Eucommia ulmoides OLIV.の樹皮を乾燥したもの
であり、顕著な血圧降下を示す。地黄茎:地黄茎は、ゴ
マノハグサ科(Scrophulariaceae)の Rehmannia gluti
nosa(GAERTN.) LIBOSCH. var. hueichingensis CHAO et
SCHIH (=R. glutinosaLIB. forma hueichingensis HSI
AO) の肥大根をそのまま(乾地黄)、または蒸して
(熟地黄)乾燥したものであり、涼血、補血に効果があ
る。 <菊花>菊花は、解熱、解毒、消炎、血圧降下作用があ
る。 <苡米>苡米は、イネ科(Gramineae)のハトムギ Coix
lacryma-jobi L. var. ma-yuen STAFF(=C. ma-yuen R
OMAN)の種皮を除いた成熟種子を乾燥したもの。 〔薬理作用〕ハトムギ種子のアセトン可溶の油状部は吉
田肉腫に対し著明な増殖阻止作用が認められた。この主
成分である coixenolideはマウスのエールリッヒ腹水癌
に対して延命効果が認められる。種子脂肪油の主成分で
ある palmitic acidは、蛙、ラット、家兎に少量で呼吸
興奮、大量でこれを麻痺させ、肺血管に対して著明な拡
張作用があり、モルヒネ及びウレタンの呼吸麻痺に桔抗
作用がある。末梢血管に対しては拡張、収縮の両作用が
あり、血圧下降作用がある。子宮に対しては一般に促進
的に作用し、アドレナリン適用後はその興奮作用を逆転
させる。腸管に対しては低濃度で収縮、高濃度で弛緩さ
せる。 <銀杏葉>銀杏葉は、その主成分がフラボノイドであ
り、毛細血管鴨部を正常化(保護)し、血小板凝葉をコ
ントロールし、血管を詰まらせて梗塞の原因となる血栓
の生成を防ぎ、血液の流れをスムーズにする働きを持っ
ている。 <陳皮>陳皮はミカン科(Rutaceae)のオオベニミカン
Citrus tangerinaHORT. ex TANAKA (大紅蜜柑、福
橘)およびコベニミカン C. erythrosa TANAKA(朱橘)
の成熟あるいは未成熟果皮を乾燥したものである。ま
た、日本産はウンシュウミカン C. unshiu MARC.(=C. a
urantium L. subsp. nobilis MAKINO var. unshiu MAKI
NO)(陳皮)及びコウジ C. leiocarpa HORT. ex TANAKA
(=C. nobilis LOUR. subsp. suntara ENGL. var. kooj
i TANAKA)(柑子、橘皮)を用いる。 <霊芝>霊芝
は、サルノコシカケ科(Polyporaceae)のマンネンタケ
Ganoderma lucidum (LEYSS. ex FR.) KARST. またはそ
の近縁種の子実体を乾燥したものであり、中枢神経系抑
制、鎮咳、除痰作用がある。 <大麦>大麦は、世界中に広く栽培される主要な穀物
で、重要な穀物であるとともに、その穀粒を発芽させた
麦芽は多量のヂアスターゼを含み、でんぷんの糖化力が
強い。 <メラトニン>メラトニンは鎮静効果のあるホルモンと
して知られている。植物中にタンパク質の一種として存
在し、天然のものは、海藻や牡蛎或いはトウモロコシな
どから抽出可能である。
It is desirable to further add one or more of the following components to the above. The content of each component is shown. <Pearl mother> Pearl mother is pearl calcium (beta calc)
It is. Calcium is not only very important as a main component of the skeleton and the teeth, but it has been revealed that when the calcium concentration in the blood decreases, the excitability of nerves further increases. Insomnia requires calcium intake.
As calcium, there are pearl calcium, eggshell calcium, oyster shell calcium, mallow calcium, whey calcium, etc., but calcium is said to have a problem in absorption anyway, but nacre has a characteristic of high absorption efficiency . <Natsuju> Daiju is a juvenile of the family Sea buckthorn (Rhamnaceae) Ziyphus jujuba MILL. Var. Inermis (BUNGE) REH
D. (= Z. Vulgaris LAMARK var. Inermis BUNGE) or its varieties are dried and tonic. <Licorice> Glycyrrhiza glabra L. var. Gland, a licorice, is a leguminous family (Leguminosae)
uligera REG. et HERD. (= G. glanduliferaWALDSTEIN et
KITAIBEL) and Uralkan elephant (Tohoku licorice) Glycyr
ex DC. root and stron of rhizauralensis FISH. ex DC. <Gokasan> Gokasan is a Ukogi of Araliaceae.
It is the root bark and stem bark of Acanthopanax plants. Currently in the Chinese market, there are Kita Gokahide (Kougokahide, Nagiyanagi), Minamigokah,
There are three main types of red hair, five skins, of which north five skin is most frequently used. There are many more types depending on other regions. Gokahi is a medicine that removes wind, strengthens muscles, and has an analgesic effect. It is used for air removal and dehumidification by compounding a common drug, and is used for hard bones and muscles by compounding with a tonic. Therefore, it is used for rheumatism-like wind and paralysis pain, leg and knee pain,
It is also applied to various diseases such as edema. <Tonaka leaf> Tonaka leaf is a dried bark of Eucommia ulmoides OLIV. Of Eucommiaceae, and shows a remarkable blood pressure drop. Ground yellow stalk: The ground yellow stalk is Rehmannia gluti of Scrophulariaceae.
nosa (GAERTN.) LIBOSCH.var.hueichingensis CHAO et
SCHIH (= R. GlutinosaLIB.forma hueichingensis HSI
AO) radish as it is (dry ground yellow) or steamed
(Ripe ground yellow) It is dried and is effective for cool blood and blood supplementation. <Chrysanthemum> Chrysanthemum has antipyretic, detoxifying, anti-inflammatory and blood pressure lowering effects. <Cold rice> Coal rice is the coix of Gramineae
lacryma-jobi L. var. ma-yuen STAFF (= C. ma-yuen R
OMAN) dried mature seeds without the seed coat. [Pharmacological action] The acetone-soluble oily portion of the adlay seeds showed a marked growth inhibitory action against Yoshida's sarcoma. The main component, coixenolide, has a prolonged survival effect on Ehrlich ascites cancer in mice. Palmitic acid, the main component of seed fat oil, causes respiratory excitement in frogs, rats, and rabbits in a small amount, paralyzes it in large amounts, has a marked dilating effect on pulmonary blood vessels, and respiratory paralysis of morphine and urethane Has an anti-challenge effect. It has both dilation and contraction effects on peripheral blood vessels, and has a blood pressure lowering effect. It generally has a stimulatory effect on the uterus and reverses its excitatory effects after adrenaline is applied. For the intestinal tract, it contracts at low concentrations and relaxes at high concentrations. <Ginkgo biloba> Ginkgo biloba, whose main component is a flavonoid, normalizes (protects) the duck capillaries, controls platelet coagulation, prevents the formation of thrombus that causes infarction by clogging blood vessels, It has the function of smoothing blood flow. <Chen skin> Chen skin is a citrus family (Rutaceae)
Ex TANAKA (Dark mandarin orange, Fukutachi) and Cobenimikan C. erythrosa TANAKA (Zhu Tachibana)
Mature or immature pericarp is dried. In addition, Japanese-produced C. unshiu MARC. (= C. A.
urantium L. subsp.nobilis MAKINO var.unshiu MAKI
NO) (Chen skin) and Koji C. leiocarpa HORT. Ex TANAKA
(= C. Nobilis LOUR.subsp.suntara ENGL.var.kooj
i TANAKA) (citrus, tachibana skin). <Lingzhi> Lingzhi is Polynaceae (Polyporaceae)
Ganoderma lucidum (LEYSS. Ex FR.) KARST. It is a dried substance of the fruiting body of KARST. <Barley> Barley is a major cereal that is widely cultivated worldwide, and is an important cereal. The germinated malt contains a large amount of diastatase, and the saccharification power of starch is strong. <Melatonin> Melatonin is known as a sedative hormone. It is present as a kind of protein in plants, and natural products can be extracted from seaweed, oyster, corn and the like.

【0006】上記成分の中、忘憂草と萱草花と酸棗仁と
蓮心とを30%以下、百合と合歓花と五加参と真珠母と
を20%以下、大麦と大棗、甘草を10%以下含有する
ことが好ましい。
[0006] Of the above ingredients, 30% or less of forgetfulness, kaya grass, acid jujube and lotus root, 20% or less of lily, bonsai, gokasan and nacre, and 10% of barley, jujube and licorice. % Is preferably contained.

【0007】次に実施例として、臨床観察結果を示す。 <実施例>忘憂草、萱草花、酸棗仁、百合、合歓花、蓮
心、大棗、甘草、五加参及び大麦を刻み、下記比率で配
合し、これに真珠母の粉末を加え、水にて抽出し、真空
乾燥させて、エキス粉とした。これに賦形材として澱粉
を混ぜ、200mgに打錠した。成分比は次の通りであ
る。01を15%、萱草花と合歓花と真珠母と五加参と
を10%、酸棗仁を18%、大麦と大棗と甘草とを7
%、百合と蓮心とを3%含有する上記組成物について1
995年12月〜1996年7月まで、長春中医学院付
属病院内科及び吉林省人民病院の中医科と連携しての臨
床治療効果及び安全性について臨床観察を行った。その
結果を以下示す。
Next, the results of clinical observation will be shown as examples. <Example> Chocolate blossom, Kaya grass flower, acid jujube, lily, yuhuana, lotus root, jujube, licorice, gosan and barley are chopped, blended in the following ratio, and the mother of pearl powder is added thereto. , And dried under vacuum to obtain an extract powder. This was mixed with starch as an excipient, and pressed into 200 mg tablets. The component ratio is as follows. 01, 15%, Kayaso, Ganhua, Pearl Mother, Gosan, 10%, Satsumitsu Jin 18%, Barley, Daijutsu, and Licorice 7
% Of the composition containing 3% of lily and lotus root.
From December 995 to July 1996, clinical observations were made on the clinical treatment effect and safety in cooperation with the Changchun Medical School Hospital Internal Medicine and the Jilin Provincial People's Hospital's Central Medicine. The results are shown below.

【0008】一、臨床資料 全部で、130例を観察し、そのうち治療組100例
で、対照組は30例である。 主に精神機能性疾病を選択する。例えば、神経症、自律
神経失調症などである。病状は中度以上のものを主とす
る。 治療組と対照組の症例では性別、年齢、経過及び病状が
相似しており、統計学的処理を経し、顕著な差異が認め
られなかったので、比較性がある。
1. Clinical data A total of 130 cases were observed, of which 100 were in the treatment group and 30 were in the control group. Mainly select mental illness. For example, neurosis, autonomic imbalance, and the like. The condition is mainly moderate or higher. The cases of the treated group and the control group are similar in gender, age, course, and medical condition, have undergone statistical processing, and have no significant differences.

【0009】二、症例選択 (一)診断標準: 1、中医診断標準:不眠、よく夢を見る、動悸、頭痛、
めまい等の症状を呈する者。 2、中医辨証標準:よく夢を見、目が覚めやすく、動
悸、健忘、四肢倦怠、精神疲労、食欲不振、顔色が悪
く、艶がない。舌質が淡白、舌体が胖大、舌苔が白い。
脈が沈細で無力で、中医辨証では、心脾両虚の者に属す
る。 3、西洋医学的な診断標準:『内科学』(高等医学院校
統一教材第3版)にある神経症、更年期障害、疲労症候
群、老人性憂鬱病などの診断標準に当てはまるもの。 (二)選択症例及び排除症例 1、選択症例 不眠の典型の症例があり、一ヶ月以上続くもので、中医
の診断標準、中医の辨証標準、西洋医学的な診断標準に
当てはまるもの。 2、排除症例 (1)不眠、動悸、頭痛等の症状は全身性疾患によるも
のである。例えば、疼痛、発熱、手術及び周囲環境の影
響によるもの。 (2)年齢は18歳未満或いは65歳以上の者、妊娠中
或いは授乳中の婦人、無憂片に過敏なもの。 (3)心血管、肺臓、肝臓、腎臓及び造血系などの重い
疾患を合併しているもの。精神病の患者。 (4)選択標準に当てはまらず、服用ルールを守らな
い、治療効果が判断不能、資料が不備で治療効果や安全
性の判断に影響を与えるもの。
2. Case selection (1) Diagnosis standard: 1, Chugoku diagnosis standard: insomnia, dreaming often, palpitations, headache,
Those who show symptoms such as dizziness. 2. Chuei Bensho Standard: Dreamy, easy to wake up, palpitations, amnesia, limb malaise, mental fatigue, loss of appetite, poor complexion, dullness. The tongue is pale, the tongue is large, and the tongue coating is white.
The pulse is thin and helpless. 3. Western medical diagnostic standards: those that apply to the diagnostic standards for neuropathy, menopause, fatigue syndrome, senile depression, etc. in "Internal Medicine" (University of Higher Medical School Third Edition). (2) Selected cases and excluded cases 1. Selected cases There are typical cases of insomnia, which last for more than one month, and which meet the diagnostic standards of the Chinese physician, the Bensho standard of the Chinese physician, and the Western medical diagnostic standards. 2. Exclusion cases (1) Symptoms such as insomnia, palpitations, and headache are due to systemic diseases. For example, due to pain, fever, surgery and the effects of the surrounding environment. (2) Those under the age of 18 or over 65, pregnant or lactating women, and those who are sensitive to anxiety. (3) Those with severe diseases such as cardiovascular, lung, liver, kidney and hematopoietic system. Psychiatric patients. (4) Those that do not meet the selection standards, do not adhere to the dosing rules, cannot determine the therapeutic effect, and have inadequate data that affect the therapeutic effect and safety judgment.

【0010】三、観察指標 (一)観察内容 1、睡眠時間、寝付き、覚醒状況、覚醒後の精神状態。 2、随伴症状、例えば、動悸、頭痛、めまい、手足の冷
えなどの症状の改善度。 3、疲労の回復力、感染に対する抵抗力、健康レベルの
向上、血液の一般検査、血中脂質、免疫グロブリンの改
善程度。 (二)治療効果の判定標準 この標準は『中薬新薬臨床研究指導原則』p186に不眠新
薬臨床研究指導原則に基づいて制定されたものである。 1、症状採点標準 (1)症状を自ら言うと、4点或いは(+++)を記録
する。 (2)答えた症状であるが、特別に顕著或いは持続の症
状であれば、3点或いは(++)を記録する。 (3)症状が重くなったり、軽くなったりしてよく変わ
る。或いは間断的に出現すると、2点或いは(+)を記
録する。 (4)症状がたまにしか出現しないものは1点或いは
(±)を記録する。 (5)症状が完全に消失すると、0点或いは(−)を記
録する。 2、治療効果標準 (1)臨床治癒:睡眠時間が正常に回復或いは夜間睡眠
時間を6時間以上に保つ。熟睡ができ、覚醒後、気分が
良く、正常に仕事ができる。半年以上再発しないもの。 (2)著効:睡眠や体力が明らかに改善され、睡眠時間
が3時間以上に増加し、睡眠の深さが増加されたもの。 (3)有効:症状が軽減したが、睡眠時間が3時間未満
のもの。 (4)無効:治療後、睡眠や随伴症状がいずれも改善さ
れず、或いはかえって悪化したもの。
3. Observation indices (1) Contents of observation 1. Sleep time, falling asleep, arousal status, mental state after awakening. 2. Concomitant symptoms such as palpitations, headaches, dizziness, cold limbs, etc. 3. Fatigue recovery, resistance to infection, improvement of health level, general examination of blood, improvement of blood lipid and immunoglobulin. (2) Standards for judging therapeutic effects This standard was established based on the principles of clinical research guidance for insomnia new drugs in “Principles for Clinical Research in New Drugs”, p.186. 1. Symptom scoring standard (1) Speak the symptoms by yourself and record 4 points or (++). (2) If the symptom is a remarked symptom, if it is a particularly prominent or persistent symptom, score 3 points or (++). (3) Symptoms often change as they become more severe or lighter. Or, when it appears intermittently, two points or (+) are recorded. (4) If the symptom appears only occasionally, record 1 point or (±). (5) When the symptoms disappear completely, a score of 0 or (-) is recorded. 2. Therapeutic effect standard (1) Clinical cure: sleep time is restored to normal or night sleep time is kept at 6 hours or more. He sleeps well, feels good after awakening, and can work normally. Those that do not recur for more than six months. (2) Significant effect: Sleep and physical strength are clearly improved, sleep time is increased to 3 hours or more, and sleep depth is increased. (3) Effective: Symptom reduced, but sleep less than 3 hours. (4) Ineffective: Those in which neither sleep nor accompanying symptoms have been improved or worsened after treatment.

【0011】四、治療方法 (一)選択された症例は全部、あらゆる鎮静薬及び滋養
強壮剤を中止する。 (二)観察症例に上記した本発明組成物の錠剤を経口で
投与する。起床時3錠、就寝前3錠で、4週間を1クー
ルとする。 (三)130例の選択された症例を随意に投与治療組と安
神補脳液組に分け、投与組を100例にし、対照組を30例
とする。 (四)対象組の案神補脳液組に朝晩2回で1アンプルず
つを投与する。4週間を1クールにする。
4. Methods of treatment (1) All sedatives and nourishing tonics should be discontinued in all selected cases. (2) The tablet of the composition of the present invention described above is orally administered to the observed case. Three tablets at wake-up and three tablets before bedtime, one week for four weeks. (3) The 130 selected cases are optionally divided into a treatment group and an Anjin supplementation fluid group. The administration group is 100 cases and the control group is 30 cases. (4) One ampoule is administered twice a morning and evening to the target group's brain solution. Make 4 weeks 1 cool.

【0012】五、治療効果 (一)総合治療効果 1、総有効率及び治療組との対照組の治療効果の比較5. Therapeutic effects (1) Overall therapeutic effects 1. Total effective rate and comparison of therapeutic effects with control group and control group

【0013】[0013]

【表1】 [Table 1]

【0014】表1から見ると、本発明組成物は神経機能
性疾患に顕著な治療効果があり、治癒率と著効率が比較
的に高く、統計学的処理の結果、対照組より優秀であっ
た。 2、治療前後の睡眠時間の変化
From Table 1, it can be seen that the composition of the present invention has a remarkable therapeutic effect on neurofunctional diseases, has a relatively high cure rate and a remarkable efficiency, and is superior to the control group as a result of statistical processing. Was. 2. Changes in sleep time before and after treatment

【0015】[0015]

【表2】 [Table 2]

【0016】表2からみると、睡眠時間は治療後明らか
に延びたことがわかる。統計学的な処理の結果、顕著な
差異が認められた。 (二)本発明組成物における睡眠症状の改善
It can be seen from Table 2 that the sleep time was clearly increased after the treatment. As a result of the statistical treatment, a remarkable difference was observed. (2) Improvement of sleep symptoms by the composition of the present invention

【0017】[0017]

【表3】 [Table 3]

【0018】表3から見ると、本発明組成物は睡眠に関
する症状に著明な改善作用があり、治療前と後に顕著な
差異が認められた。とりわけ再度寝付き困難及び朝起き
るときの不適感が特に改善された。 (三)睡眠随伴症状の改善
As can be seen from Table 3, the composition of the present invention has a remarkable ameliorating effect on symptoms related to sleep, and a remarkable difference was observed before and after the treatment. Especially the difficulty in falling asleep again and the discomfort when waking up in the morning have been particularly improved. (3) Improvement of sleep related symptoms

【0019】[0019]

【表4】 [Table 4]

【0020】表4から見ると、睡眠に随伴する症状が著
明に改善され、特に頭痛、手足の冷えと倦怠感、無力感
の改善は明らかである。 (四)治療前後、舌と脈の改善
As can be seen from Table 4, the symptoms associated with sleep are remarkably improved, and in particular, headache, coldness of limbs and fatigue, and improvement of helplessness are apparent. (4) Improvement of tongue and pulse before and after treatment

【0021】[0021]

【表5】 [Table 5]

【0022】表5から見ると、本発明組成物は治療組の
舌と脈に著明な作用があり、好転率は95%以上、対照組
は好転率で75%で、治療組は対照組より優秀であること
がわかる。 (五)治療前後免疫グロブリンの変化
As can be seen from Table 5, the composition of the present invention has a remarkable effect on the tongue and pulse of the treatment group, the turnover rate is 95% or more, the control set is 75% in turnover, and the treatment set is the control set. It turns out that it is more excellent. (5) Changes in immunoglobulin before and after treatment

【0023】[0023]

【表6】 [Table 6]

【0024】表6からみると、本発明組成物は著明に免
疫グロブリンを増加させる作用があり、治療後は治療前
より明らかに改善されたことがわかる。 (六)血中脂質の改善
Table 6 shows that the composition of the present invention has a remarkable effect of increasing immunoglobulin, and is clearly improved after the treatment compared to before the treatment. (6) Improvement of blood lipids

【0025】[0025]

【表7】 [Table 7]

【0026】表7からみると、本発明組成物は著明な血
中脂質を減少させる作用があり、治療後は治療前より改
善されたことがわかる。 (七)治療前後血液一般検査の変化 130例の内の10人は治療前赤血球・ヘモグロビンが正常
値より低く、治療後は治療前より回復した。その他の12
0例では治療前後に変化はなかった。
From Table 7, it can be seen that the composition of the present invention has a marked blood lipid-reducing effect, and is improved after treatment as compared to before treatment. (7) Changes in pre- and post-treatment blood general tests Ten of the 130 patients had lower than normal levels of pre-treatment red blood cells and hemoglobin, and recovered after pre-treatment. Other 12
In 0 cases, there was no change before and after treatment.

【発明の効果】【The invention's effect】

【0027】以上説明したように本発明の組成物によれ
ば、神経機能疾患や睡眠症状の改善などに効果があり、
ストレス軽減効果を得られる。
As described above, the composition of the present invention is effective for improving nervous function diseases and sleep symptoms.
A stress reduction effect can be obtained.

Claims (7)

【特許請求の範囲】[Claims] 【請求項1】 忘憂草を主成分とするストレス軽減効果
のある組成物。
1. A composition having a stress-reducing effect, which is mainly composed of forgetfulness.
【請求項2】 忘憂草と萱草花とを主成分とするストレ
ス軽減効果のある組成物。
2. A composition having a stress-reducing effect, which is mainly composed of forget-me-not and herbaceous flowers.
【請求項3】 忘憂草と萱草花と酸棗仁と百合と合歓花
と蓮心とを主成分とするストレス軽減効果のある組成
物。
3. A composition having a stress-reducing effect comprising, as main components, forget-me-not, herbaceous flower, acid jujube, lily, lily flower and lotus heart.
【請求項4】 忘憂草と萱草花と酸棗仁と百合と合歓花
と蓮心とを主成分とし、更に下記の成分の中の1以上を
含有することを特徴とするストレス軽減効果のある組成
物。真珠母、大棗、甘草、五加参、杜仲葉、地黄茎、菊
花、苡米、銀杏葉、陳皮、霊芝、大麦。
4. A composition having a stress-reducing effect, which is mainly composed of forget-me-not grasses, hayaku flowers, acid jujubes, lilies, happi flowers, and lotus roots, and further contains one or more of the following components. Stuff. Mother of pearl, large jujube, licorice, five ginseng, eucalypt, ground yellow stalk, chrysanthemum, ox rice, ginkgo biloba, cinnabar, reishi, barley.
【請求項5】 忘憂草と萱草花と酸棗仁と蓮心とを30
%以下、百合と合歓花と五加参と真珠母とを夫々20%
以下、大麦と大棗と甘草とを夫々10%以下を含有する
ことを特徴とするストレス軽減効果のある組成物。
5. A mixture of forget-me-nots, kaya-so, acid soju and lotus root.
% Or less, 20% each for Yuri, Yuhanka, Gokasan and Pearl Mother
A composition having a stress-reducing effect, comprising 10% or less of each of barley, jujube and licorice.
【請求項6】 忘憂草を15±5%、萱草花と合歓花と
真珠母と五加参とを夫々10±5%、酸棗仁を18±5
%、大麦と大棗と甘草とを夫々7±5%、百合と蓮心と
を夫々3±3%含有することを特徴とするストレス軽減
効果のある組成物。
6. The forgetfulness is 15 ± 5%, the flower of kaya flower, the happi flower, the mother of pearl and the ginseng are each 10 ± 5%, and the content of sojuju is 18 ± 5%.
%, Barley, jujube, and licorice, respectively, 7 ± 5%, and lily and lotus root, respectively, 3 ± 3%.
【請求項7】 メラトニン5±3%以下を更に添加し
た、 請求項1又は請求項2又は請求項3又は請求項4又は請
求項5に記載のストレス軽減効果のある組成物。
7. The composition having a stress-reducing effect according to claim 1, further comprising 5 ± 3% or less of melatonin.
JP9347191A 1997-12-02 1997-12-02 Composition having alleviating effect on stress Pending JPH11158077A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9347191A JPH11158077A (en) 1997-12-02 1997-12-02 Composition having alleviating effect on stress

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9347191A JPH11158077A (en) 1997-12-02 1997-12-02 Composition having alleviating effect on stress

Publications (1)

Publication Number Publication Date
JPH11158077A true JPH11158077A (en) 1999-06-15

Family

ID=18388544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9347191A Pending JPH11158077A (en) 1997-12-02 1997-12-02 Composition having alleviating effect on stress

Country Status (1)

Country Link
JP (1) JPH11158077A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007520419A (en) * 2003-08-28 2007-07-26 株式会社ピュウリメッド Lotus extract for the treatment of depression
JP2008501789A (en) * 2004-06-09 2008-01-24 ピュリメド カンパニー リミテッド Lotus extract for preventing or treating ischemic heart disease, pharmaceutical composition containing the same and health food
WO2008146883A1 (en) * 2007-05-29 2008-12-04 Osaka Bioscience Institute Sleep-improving agent
WO2009145363A1 (en) * 2008-05-30 2009-12-03 ソムノクエスト株式会社 Composition comprising a hot water extract of hemerocallis plants, said composition being effective in treating fatigue by having antidepressant properties or by improving sleep
US7799802B2 (en) 2004-08-03 2010-09-21 Institstute of Oriental Medical Science Inc. Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation
CN103976322A (en) * 2014-06-06 2014-08-13 四川省宕府王食品有限责任公司 Method for preparing seasoning dish with daylily as raw material
CN111329012A (en) * 2018-12-19 2020-06-26 云南苗晨生物科技有限公司 Preparation method of edible aerosol with calming and sleep-aiding functions

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007520419A (en) * 2003-08-28 2007-07-26 株式会社ピュウリメッド Lotus extract for the treatment of depression
JP2008501789A (en) * 2004-06-09 2008-01-24 ピュリメド カンパニー リミテッド Lotus extract for preventing or treating ischemic heart disease, pharmaceutical composition containing the same and health food
US7799802B2 (en) 2004-08-03 2010-09-21 Institstute of Oriental Medical Science Inc. Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation
WO2008146883A1 (en) * 2007-05-29 2008-12-04 Osaka Bioscience Institute Sleep-improving agent
WO2009145363A1 (en) * 2008-05-30 2009-12-03 ソムノクエスト株式会社 Composition comprising a hot water extract of hemerocallis plants, said composition being effective in treating fatigue by having antidepressant properties or by improving sleep
JPWO2009145363A1 (en) * 2008-05-30 2011-10-20 ソムノクエスト株式会社 A composition having an antidepressant-like action or a fatigue recovery action by improving sleep, comprising a hot water extract of a forget-me-not plant
CN103976322A (en) * 2014-06-06 2014-08-13 四川省宕府王食品有限责任公司 Method for preparing seasoning dish with daylily as raw material
CN111329012A (en) * 2018-12-19 2020-06-26 云南苗晨生物科技有限公司 Preparation method of edible aerosol with calming and sleep-aiding functions

Similar Documents

Publication Publication Date Title
KR101787432B1 (en) Method for manufacturing oriental medicine composition which improves menorrhagia and dysmenorrhea comprising fermented velvet antler and yeast hydrolysate
KR20100105346A (en) Composition for immune enhancement comprising the extract of young antler, cornus officinalis, ligusticum acutilobum, chinese matrimony vine, yam, aurantii nobilis pericarpium, gastrodia elata blume, agastache rugosa, cinnamomum loureirii, ginseng steamed red and schizandra chinensis, as an active ingredient
CN107029146A (en) A kind of clearing lung and eliminating phlegm air making-up and spleen enlivening supports Chinese medicine composition of lung and preparation method thereof
KR101855821B1 (en) Composition for relieving of menopausal symptoms and improving blood circulation
KR100947278B1 (en) A carbohydrate and lipid absorption inhibitory nelumbo composition and its manufacturing process thereof
JP2002275086A (en) Composition for improving valetudinarianish
CN103961614B (en) Chinese medicine composition for treating respiratory disease and its production and use
CN108208456A (en) A kind of feed addictive for improving laying rate of laying hen and preparation method thereof
CN106177477A (en) A kind of health composition for blood sugar lowering, blood fat reducing and blood pressure lowering
JPH11158077A (en) Composition having alleviating effect on stress
KR20160000695A (en) Herbal-medicine containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same
CN114224998B (en) Traditional Chinese medicine composition, preparation and application for treating spleen-kidney yang deficiency type functional dyspepsia
TW202330006A (en) Composition for preventing, improving or alleviating symptoms relating to qi deficiency and/or blood deficiency
CN108186966A (en) A kind of composition for preventing or improving senile dementia and its application
CN106822660A (en) A kind of Chinese medicine preparation for treating cardiovascular and cerebrovascular disease
CN106376930A (en) Nutritional medicinal diet powder for treating chronic diarrhoea and preparation method thereof
CN112402569A (en) Anti-fatigue health product and preparation method thereof
CN110279809A (en) A kind of composition of enriching yin and nourishing kidney and the preparation method and application thereof
CN108432968A (en) A kind of feed addictive and preparation method thereof for improving beaver rabbit fur quality
CN111328967A (en) Method for preparing health porridge for hyperlipidemia patients
CN104258224A (en) Schisandra chinensis oral solution for treating lung-and-kidney yin-deficiency type chronic bronchitis and preparation method thereof
CN108552432A (en) A kind of egg feedstuff and preparation method thereof improving laying rate of laying hen
CN113499402B (en) Traditional Chinese medicine composition for treating irritable bowel syndrome and preparation method thereof
CN112089783B (en) Application of traditional Chinese medicine composition in preparation of medicine for preventing or/and treating obesity
CN106728392B (en) Traditional Chinese medicine for treating liver-stagnation and spleen-deficiency type impotence and preparation method thereof

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees